beyondgenome.com
Featured Conference Session, Monday, June 16th:
RNAi: Functional Genomics and Target Validation
Presentations Include:
RNAi-Based Validation Platform for Rapid Functional Characterization
of Brain Disease-Related Genes
Dr. Li Gan, Senior Scientist, Department of Molecular Biology & Protein Chemistry,
AGY Therapeutics
Tools for Expediting Target Validation
Dr. Mark Nuttal, Section Leader, GlaxoSmithKline
Knockdown in Target Validation
Dr. Kathrin Heermeier, Senior Scientist, Aventis Pharma
Development of a Robust Screen for Active siRNA Duplexes
and Using siRNA Technology for Target Validation
Mr. Xu Ren, Research Scientist, Amgen Corp.
Arrayed Adenoviral Knockdown Vectors for Target Discovery and Validation
Dr. Helmuth van Es, Director of Molecular and Cellular Biology, Galapagos Genomics;
and Dr. Michael Briggs, Director of Genomics, Pharmacia Corporation
Genomewide Knockdown Strategies: RNAi Applications
Dr. Thierry Bogaert, Chief Executive Officer, Devgen nv |
